Medtronic launches five-year post-approval study for Altaviva, a 44 mm neurostimulator implanted without sedation or imaging
Brian Buntz
The medical device giant Medtronic won approval for its Altaviva implant, a tibial neurostimulator, in September. The device, roughly half the length of a stick of chewing gum (43.7 × 15.7 × 4.5 mm, 7.5 g), recently won a 2026 Edison Award for health innovation. Most recently, Medtronic recently enrolled its first patient in the… The post Medtronic launches five-year post-approval study for Altaviva, a 44 mm neurostimulator implanted without sedation or imaging appeared first on Research & Devel